IGF1 and metabolic syndrome: Friedrich et al. (2013) showed that participants with the MetS had significantly higher IGF-1 levels vs healthy age-matched controls [18], whereas no significant differences were observed for IGF-1 between any of the respective groups in the current study, which is in agreement with the findings of Kabir et al. (2010) [29].